Real-World Costs of Early vs Late OnabotulinumtoxinA Treatment for Post-Stroke Spasticity: A Retrospective Claims Analysis

被引：0

作者：

Esquenazi, Alberto ^{[1
]}

List, Cassandra ^{[2
]}

Bloudek, Lisa ^{[3
]}

Brouwer, Elizabeth ^{[3
]}

Lee, Woojung ^{[3
]}

Elsea, David ^{[3
]}

Kang, Ashley ^{[3
]}

Tung, Amy ^{[4
]}

Lee, Jae ^{[4
]}

Bohart, Zach ^{[5
,6
]}

机构：

[1] MossRehab, Einstein Healthcare Network, Elkins Pk, PA USA

[2] Brooks Rehabil, Jacksonville, FL USA

[3] Curta Inc, Seattle, WA USA

[4] AbbVie, 2525 Dupont Dr, Irvine, CA 92612 USA

[5] Tufts Med Ctr, Boston, MA USA

[6] Brown Univ, Warren Alpert Med Sch, Providence, RI USA

来源：

TOXICON | 2024年 / 237卷

关键词：

OnabotulinumtoxinA; Post-stroke spasticity;

D O I：

10.1016/j.toxicon.2024.107395

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：25 / 26

页数：3

共 28 条

[21] Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX study
Patel, Atul T.
Ward, Anthony B.
Geis, Carolyn
Jost, Wolfgang H.
Liu, Chengcheng
Dimitrova, Rozalina
JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (12) : 1619 - 1629
[22] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
Dikmen, Pinar Yalinay
Kosak, Seda
Aydinlar, Elif Ilgaz
Kocaman, Ayse Sagduyu
ACTA NEUROLOGICA BELGICA, 2018, 118 (03) : 475 - 484
[23] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
Pınar Yalinay Dikmen
Seda Kosak
Elif Ilgaz Aydinlar
Ayse Sagduyu Kocaman
Acta Neurologica Belgica, 2018, 118 : 475 - 484
[24] Botulinum toxin type A for the treatment of patients with post-stroke spasticity in Thailand: cost-utility and budget impact analysis
Hadnorntun, Phorntida
Prawjaeng, Juthamas
Kongmalai, Tanawan
Tanvijit, Phakamas
Chueluecha, Chuenchom
Jintakul, Nawarat
Saringcarinkul, Tipyarat
Srinonprasert, Varalak
Kumthornthip, Witsanu
Leelahavarong, Pattara
BMJ OPEN, 2025, 15 (01):
[25] Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
Lanteri-Minet, Michel
Ducros, Anne
Francois, Clement
Olewinska, Elzbieta
Nikodem, Mateusz
Dupont-Benjamin, Laure
CEPHALALGIA, 2022, 42 (14) : 1543 - 1564
[26] Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal
Andreou, A. P.
Trimboli, M.
Al-Kaisy, A.
Murphy, M.
Palmisani, S.
Fenech, C.
Smith, T.
Lambru, G.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (08) : 1069 - +
[27] Real-world treatment patterns and healthcare resource utilization among migraine patients: a German claims database analysis
Gaul, Charly
Seidel, Karolin
Heuck, Alexander
Silaidos, Carmina
Mrosowsky, Thora
Eberhardt, Alice
Fritz, Bjorn
Jacob, Christian
JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 667 - 678
[28] Comprehensive Observational and Longitudinal study on the Outbreak of Stroke-related Spasticity focusing on the Early Onset management with Botulinum NeuroToxin (COLOSSEO-BoNT): protocol for a real-world prospective observational study on upper limb spasticity
Marano, Massimo
Suppa, Antonio
Palmieri, Maria Giuseppina
Cecconi, Emanuela
Frisullo, Giovanni
Bovenzi, Roberta
Riso, Vittorio
Anzini, Alexia
Brienza, Marianna
Anticoli, Sabrina
Crupi, Domenica
Giovannelli, Morena
Massimiani, Andrea
Rinalduzzi, Steno
Morena, Emanuele
Massara, Maria Carlotta
Cupini, Letizia
Bressi, Federica
Pilato, Fabio
Maggi, Loredana
Sauchelli, Donato
Iezzi, Ennio
Centonze, Diego
Aprile, Irene
Di Lazzaro, Vincenzo
Toni, Danilo
Altavista, Maria Concetta
BMJ OPEN, 2024, 14 (06): : 1 - 9

← 1 2 3 →